Study 4 of 23Retatrutide (LY3437943) literatureBMJ (Clinical research ed.)Top journal2026
Retatrutide fact check: Has a man died after taking the unapproved weight loss jab?
Not reported in abstract.
Where it sits
this study against the rest of the retatrutide (ly3437943) corpus9
Preclinical · this one
7
Observational
0
Open-label
1
Randomised
6
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.20). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
- Not reported in abstract.
Elsewhere in the Retatrutide (LY3437943) corpus
BSustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome.JCEM case reports · 2026 · n=1 · Total weight loss of 58.8% (-108.7 kg) at 18 months.HumanCCagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats.Nature metabolism · 2026 · Not reported in abstract.AnimalDObstructive sleep apnea, GLP-1 receptor agonist pharmacotherapy, and the oral microbiome: competing biological influences and implications for oral health monitoring.Clinical oral investigations · 2024 · Not reported in abstract.reviewCCagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male rats.Nature metabolism · 2026 · Not reported in abstract.AnimalBDetection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.Rapid communications in mass spectrometry : RCM · 2023 · n=4 · Limits of detection (LOD) were 6.14 ng/mL in plasma and 2.44 ng/mL in urine.HumanBDetection and Excretion Profile of Retatrutide in Human Plasma and Urine by LC-HRMS: Implications for Antidoping Analysis.Rapid communications in mass spectrometry : RCM · 2023 · n=4 · Limits of detection in plasma were 6.14 ng/mL and in urine were 2.44 ng/mL.Human